SYMBIOTEC vs M&MFIN: Stock Comparison
Head-to-head financial and trading comparison between Symbiotec Pharmalab Limited (SYMBIOTEC) and Mahindra & Mahindra Financial Services Limited (M&MFIN) in the Cross-Sector Peers sector.
SYMBIOTEC
NSE: SYMBIOTECM&MFIN
NSE: M&MFINKey Metrics Comparison Table
| Metric | SYMBIOTEC | M&MFIN | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹1,087.50 | ₹319.45 | — |
| 1-Year Price Return | -0.93% | +5.22% | M&MFIN (6.15% higher) |
| 52-Week High | ₹1,198.00 | ₹412.30 | — |
| 52-Week Low | ₹1,003.35 | ₹275.70 | — |
| 30-Day Annualized Volatility | 53.35% | 26.44% | M&MFIN (Steadier) |
| 30-Day Average Daily Volume | 2,798,957 | 1,848,112 | SYMBIOTEC (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between SYMBIOTEC and M&MFIN, which stock gave better returns over the last year?
M&MFIN has outperformed SYMBIOTEC over the past 12 months with a gain of 5.22% compared to -0.93%.
Which stock is less volatile: SYMBIOTEC or M&MFIN?
M&MFIN demonstrated lower price volatility (26.44% annualized) compared to SYMBIOTEC (53.35%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of SYMBIOTEC vs M&MFIN?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are SYMBIOTEC and M&MFIN direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.